PPARγ are expressed in a variety of tumor cells and PPARγ agonists e.g Thiazolidinediones (TZDs), and tyrosine based agonists show cytostatic and cytotoxic activity against tumor cells in vitro and in vivo brought about by regulating proteins involved in growth regulatory pathways and cell cycle [7]. The gene discussed is PPARG; the disease is neoplasm.